SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sonus Pharma (SNUS) ? Opinions

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (371)9/21/2007 4:34:49 PM
From: tuck  Read Replies (2) of 384
 
>>Sonus Pharmaceuticals to Hold Conference Call to Discuss Results from Pivotal Phase 3 Trial of TOCOSOL(R) Paclitaxel
Friday September 21, 4:30 pm ET

BOTHELL, Wash.--(BUSINESS WIRE)--Sonus Pharmaceuticals, Inc. (NASDAQ:SNUS - News) today announced that it will hold a conference call on Monday, September 24, to discuss the results from the pivotal Phase 3 clinical trial of TOCOSOL® Paclitaxel, the Company's lead oncology product candidate.

The conference call will be webcast live on September 24 at 5:00 A.M. PT/8:00 A.M. ET and can be accessed at www.sonuspharma.com/events.html. The call will be archived at the same link. A telephone replay will be available on September 24 at 7:00 A.M. PT/10:00 A.M. ET for one week at 800-405-2236 or 303-590-3000 for international calls; Pass code: 11098211.<<

snip

Holding small position with fingers crossed. I'm overdue for a win when facing clinical risk. Stock is currently up slightly after hours.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext